Nacuity Pharmaceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-30.
Nacuity Pharmaceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 30, 2025. The filing reports $8.39M sold. Its industry group is Pharmaceuticals. It names Halden Conner (Executive Officer, Director), David Wohlberg (Executive Officer, Director), Gerald Cagle (Director) (SEC Form D, December 30, 2025).
Sell to companies like Nacuity Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Nacuity Pharmaceuticals, Inc.
Free to see. No signup.
More on the people and the money behind Nacuity Pharmaceuticals, Inc., from the filings we hold.
Maxim Group LLC received sales compensation on this raise and on 9 other raises we hold, nearest in date first:
Pharmaceuticals raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when Nacuity Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Nacuity Pharmaceuticals, Inc. raises, hires or launches. No email unless you switch it on.
Watch Nacuity Pharmaceuticals, Inc. →Get the full cited report on Nacuity Pharmaceuticals, Inc.
What the filing shows about Nacuity Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Nacuity Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Nacuity Pharmaceuticals, Inc. See pricing
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $8.39M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Halden Conner is named as Executive Officer and Director on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
David Wohlberg is named as Executive Officer and Director on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Gerald Cagle is named as Director on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Emmett Cunningham, Jr. is named as Director on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Rusty Kelley is named as Director on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Robin Steele is named as Director on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Benjamin Yerxa is named as Director on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Jami Kern is named as Executive Officer on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Charles Lieser is named as Executive Officer on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
Michael Wall is named as Executive Officer on the Form D that Nacuity Pharmaceuticals, Inc. filed with the SEC on 30 December 2025, one of 10 people that filing names.
10 people named on the filing — 5 holding an executive role and 5 as directors only.
Named as of the 2025-12-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Nacuity Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Nacuity Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nacuity Pharmaceuticals, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Nacuity Pharmaceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Nacuity Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Nacuity Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Dallas-Fort Worth
https://mentionfox.com/funding/nacuity-pharmaceuticals-inc-form-d-25000001